Sun, May 19, 2013, 11:58 PM EDT - U.S. Markets closed
Amarantus Bioscience - AMBS. Currently trading at .08. Company's pateneted MANF technology could be worth billions long term. Due diligence before a "big pharma" buyout or partnership is announced.
Best opportunity in the market currently trading at under a dime. Read the recent Yahoo news.
Take the time to check it out. Tremendous upside as a potential takeover target.